Gene · 3003
NIH grants2,103
NIH grants whose papers are about the gene, through NIH's grant-paper links.
701 to 720 of 2,103
Download this page as JSON| Grant | Title | GZMK papers | Newest fiscal year |
|---|---|---|---|
| R00HG011468 | Computational Methods for Inferring Single-cell DNA Methylation and its Spatial Landscape | 1 | 2024 |
| R00LM013089 | Developing deep learning models for precision oncology | 1 | 2024 |
| R01AG063846 | Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer's from HIV-Associated Cognitive Dysfunction | 1 | 2024 |
| R01AG066707 | Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for Alzheimers Disease | 1 | 2024 |
| R01AG067014 | Intestinal Stem Cell Function During Aging and Tumor Initiation | 1 | 2024 |
| R01AI103867 | Structural correlates of T cell receptor signaling | 1 | 2024 |
| R01AI143741 | Pathogenic role of IL-17 response in Streptococcus pneumoniae nasopharyngeal pathogenesis during an influenza virus co-infection | 1 | 2024 |
| R01AI145164 | T cell-targeted lentiviral vectors with Cas9/RNP for the in vivo gene therapy of HIV-AIDS | 1 | 2024 |
| R01AI148161 | T cells in Lupus | 1 | 2024 |
| R01AI148435 | Macrophages in human autoimmune tissue pathology | 1 | 2024 |
| R01AI148740 | Altering Hepatitis B Virus assembly through pharmacological intervention | 1 | 2024 |
| R01AI148963 | Inborn Errors of Immunity Leading to Autoinflammatory Syndromes | 1 | 2024 |
| R01AI150686 | Treg cell diversity and homeostatic control | 1 | 2024 |
| R01AI151123 | The role of BAF related complexes in regulatory T cell development and function | 1 | 2024 |
| R01AI152258 | Mechanisms of increased susceptibility to pulmonary Nontuberculous Mycobacterial disease in the elderly | 1 | 2024 |
| R01AI153349 | Measuring Intralesional Drug Exposures in Cavitary TB using Noninvasive In Vivo PET Imaging | 1 | 2024 |
| R01AI154470 | Immunobiology of Influenza Virus-related Critical Illness in Young Hosts | 1 | 2024 |
| R01AI155024 | Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis | 1 | 2024 |
| R01AI161027 | New radiotracer development to study immune cell mobilization of granzyme proteolytic activity | 1 | 2024 |
| R01CA075115 | Discoidin Domain Receptor Tyrosine Kinase 2 in bladder cancer progression | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/grants?page=36